Yıl: 2020 Cilt: 21 Sayı: 3 Sayfa Aralığı: 200 - 206 Metin Dili: İngilizce DOI: 10.4274/imj.galenos.2020.52296 İndeks Tarihi: 26-10-2020

Efficacy of Sclerotherapic Agents in the Treatment of Simple Ovarian Cysts Created by Experimental Rat Model

Öz:
Introduction: The purpose of this study is to investigate theeffects of tetracycline (TC), clarithromycin (CM) and bleomycin(BLM) on the cyst diameter and ovarian tissues in the treatmentof simple ovarian cysts.Methods: We employed Wistar albino female rats (n=38) tocreate ovarian cysts, and did not intervene in any form in thecontrol group (GC) (n=6). In total, 32 female rats underwentunilateral salpingectomy for the creation of cysts. Macroscopiccysts were manifested in 25 (78%) rats who underwentsalpingectomy. We divided the rats (n=25) with cysts intofour groups. Salpingectomy with saline was performed in G1,salpingectomy with tetracycline (TC) was performed in G2, andsalpingectomy with Clarithromycin (CM) was performed in G3.Additionally, salpingectomy with BLM was exploited in G4.Results: There was a significant decrease in the diameter ofthe cyst in G2 as compared to G1, but there was no significantdifference among the other groups. There was no significantchange in total ovarian reserve in the groups (p=0.066).There was a statistically significant increase in fibrosis in G1and G3 groups as compared to GC (p<0.0001). As comparedto G1, fibrosis was significantly decreased in G2 (p=0.003) andG4 (p=0.0001). TUNEL positivity was similar in GC and G1;however, there was a significant increase of TUNEL positivityin G2, G3 and G4 as compared to the control group (p<0.0001).In addition, there was a significant increase of adhesion in G2(p=0.030) and G3 (p=0.010) as compared to G1.Conclusion: TC is a more effective agent than CM and BLM inthe sclerotherapy treatment of ovarian cysts. These three agentshave no negative effect on the total ovarian reserves. There isan increasing need for further clinical studies regarding the use of sclerotherapy agents, primarily concerning the TC, inthe treatment of simple ovarian cysts.
Anahtar Kelime:

Deneysel Rat Modeliyle Oluşturulan Basit Over Kistlerinin Tedavisinde Skleroterapik Ajanların Etkinliği

Öz:
Amaç: Basit over kistlerinin tedavisinde Tetrasiklin, Klaritromisin ve Bleomisinin kist çapı ve over dokuları üzerine etkisini araştırmak. Yöntemler: Over kistlerini oluşturmak için 38 Wistar albino rat ile çalışıldı. Kontrol grubuna (GK) (n=6) hiçbir müdahale yapılmadı. Toplam 32 dişi Wistar albino cinsi ratta ise tek taraflı salpenjektomi yapıldı. İşlemden 1 ay sonra tüm ratlara laparotomi yapıldı. Salpenjektomi yapılanların 25’inde (78%) makroskobik kist oluşmuştu. Kist oluşan ratlar (n=25) 4 gruba ayrıldı. Grup 1’e (G1) salpenjektomi ve salin, Grup 2’ye (G2) salpenjektomi ve tetrasiklin (TC), Grup 3’e (G3) salpenjektomi ve klaritromisin (CM), Grup 4’e ise (G4) salpenjektomi ve bleomisin uygulandı. Bulgular: G1 grubu ile karşılaştırıldığında G2 grubunda kist çapında anlamlı derecede azalma olduğu görüldü, diğer gruplar ile anlamlı farklılık yoktu. Kontrol grubu ile karşılaştırıldığında G1, G2, G3 ve G4 gruplarında toplam over rezervinde bir değişiklik izlenmedi (p=0.066). Kontrol grubu ile karşılaştırıldığında G1 ve G3 gruplarında fibrozis istatistiksel olarak anlamlı artış gözlendi (p<0.0001). G1 ile karşılaştırıldığında ise G2 (p=0.003) ve G4 (p=0.0001) gruplarında fibrozis istatistiksel olarak anlamlı şekilde azalmış gözlendi. TUNEL pozitifliği; GK ve G1 gruplarında benzerdi. Kontrol grubuyla kıyaslandığında ise G2, G3 ve G4 gruplarında anlamlı artış gözlendi (p<0.0001). Adhezyon G1 grubuyla karşılaştırıldığında G2 (p=0.030) ve G3 (p=0.030) gruplarında anlamlı olarak artmıştı. Sonuç: TC, over kistlerinin skleroterapisinde, klaritromisin ve bleomisinden daha etkili bir ajandır. Bu üç ajanın total over rezervleri üzerine olumsuz etkisi yoktur. Basit over kistlerinin tedavisinde TC öncelikli olmak üzere skleroterapik ajanların kullanılabilmesi için klinik çalışmalara ihtiyaç vardır.
Anahtar Kelime:

Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık
  • 1. Kafali H, Yurtseven S, Atmaca F, Ozardali I. Management of non-neoplastic ovarian cysts with sclerotherapy. Int J Gynaecol Obstet 2003; 81: 41-5.
  • 2. Liu H, Wang X, Lu D, Liu Z, Shi G. Ovarian masses in children and adolescents in China: analysis of 203 cases. J Ovarian Res 2013; 6: 47-52.
  • 3. Mittal S, Kumar S, Kumar A, Verma A. Ultrasound guided aspiration of endometrioma--a new therapeutic modality to improve reproductive outcome. Int J Gynaecol Obstet 1999; 65: 17-23.
  • 4. Marana R, Caruana P, Muzii L, Catalano GF, Mancuso S. Operative laparoscopy for ovarian cysts. Excision vs. aspiration. J Reprod Med 1996; 41: 435-8.
  • 5. Zanetta G, Lissoni A, Torri V, Valle CD, Trio D, Rangoni G, Mangioni C. Role of puncture and aspiration in expectant management of simple ovarian cysts: a randomised study. BMJ 1996; 313: 1110-3.
  • 6. Marana R, Ferrari S, Scarpa A, Muzii L. Laparoscopic treatment of adnexal cystic masses. Minerva Ginecol 2006; 58: 371-80.
  • 7. Okagaki R, Osuga Y, Momoeda M, Tsutsumi O, Taketani Y. Laparoscopic findings after ultrasound-guided transvaginal ethanol sclerotherapy for ovarian endometrial cyst. Hum Reprod 1999; 14: 270-4.
  • 8. Benagiano G, Guo S-W, Bianchi P, Puttemans P, Gordts S, Petraglia F, et al. Pharmacologic treatment of the ovarian endometrioma. Expert Opin Pharmacother 2016; 17: 2019-31.
  • 9. Hsieh C-L, Shiau C-S, Lo L-M, Hsieh T-T, Chang M-Y. Effectiveness of ultrasoundguided aspiration and sclerotherapy with 95% ethanol for treatment of recurrent ovarian endometriomas. Fertil Steril 2009; 91: 2709-13.
  • 10. Liu F-S, Hung M-J, Hwang S-F, Lu C-H, Ke Y-M, Ho ES-C. Management of pelvic lymphocysts by ultrasound-guided aspiration and minocycline sclerotherapy. Gynecol Obstet Invest 2005; 59: 130-3.
  • 11. Peterson WL, Graham DY, Marshall B, Blaser MJ, Genta RM, Klein PD, et al. Clarithromycin as monotherapy for eradication of Helicobacter pylori: a randomized, double blind trial. Am J Gastroenterol 1993; 88: 1860-4.
  • 12. Mahalingan K, Rajarajan S, Baby B, Harsha NS. Formulation and evaluation of clarithromycin extended release tablets. J Pharm Sci Res 2009; 3: 97-100. 13. Mouratis MA, Aidinis V. Modeling pulmonary fibrosis with bleomycin. Curr Opin Pulm Med 2011; 17: 355-61.
  • 14. Cai Y, Wang R, Yang S-F, Zhao Y-F, Zhao J-H. Sclerotherapy for the mucoceles of the anterior lingual salivary glands with pingyangmycin. Oral Dis 2014; 20: 473-6.
  • 15. Zhang W, Chen G, Ren J-G, Zhao Y-F. Bleomycin induces endothelial mesenchymal transition through activation of mTOR pathway: a possible mechanism contributing to the sclerotherapy of venous malformations. Br J Pharmacol 2013; 170: 1210-20.
  • 16. Atilgan R, Ozkan ZS, Kuloglu T, Kocaman N, Baspinar M, Can B, et al. Impact of intracystic ethanol instillation on ovarian cyst diameter and adjacent ovarian tissue. Eur J Obstet Gynecol Reprod Biol 2013; 174: 133-6.
  • 17. Souza AZ, Fonseca AM, Izzo VM, Clauzet RM, Salvatore CA. Ovarian histologyand function after total abdominal hysterectomy. Obstet Gynecol 1986; 68: 847-9.
  • 18. Mazaud S, Guigon CJ, Lozach A, Coudouel N, Forest MG, Coffigny H, et al. Establishment of the reproductive function and transient fertility of female rats lacking primordial follicle stock after fetal gamma-irradiation. Endocrinology 2002; 143: 4775-87.
  • 19. Sapmaz E, Kale A, Akpolat N. Melatonin use in unilateral total salpingectomy in rats. Clin Exp Obstet Gynecol 2012; 39: 186-90.
  • 20. Samrao D, Wang D, Ough F, Lin YG, Liu S, Menesses T, et al. Histologic parameters predictive of disease outcome in women with advanced stage ovariancarcinoma treated with neoadjuvant chemotherapy. Transl Oncol 2012; 5: 469-74.
  • 21. Kars B, Buyukbayrak EE, Karsidag AY, Pirimoglu M, Unal O, Turan C. Comparison of success rates of ‘transvaginal aspiration and tetracycline sclerotherapy’ versus ‘only aspiration’ in the management of non-neoplastic ovarian cysts. J Obstet Gynaecol Res 2012; 38: 65-9.
  • 22. Ashindoitiang JA. Preliminary report of the effectiveness of tetracycline sclerotherapy in treatment of ganglion. Plast Surg Int 2012: 624209-624211. 23. Francis JJ, Levine LA. Aspiration and sclerotherapy: a nonsurgical treatment option for hydroceles. J Urol 2013; 189: 1725-9.
  • 24. Fabrizzi G, Lanza C, Bolli V, Pieroni G. Symptomatic hepatic cyst in a child: treatment with single-shot injection of tetracycline hydrochloride. Pediatr Radiol 2009; 39: 1091-4.
  • 25. Kilinc M, Tufan O, Guven S, Odev K, Gurbuz R. Percutaneous injection sclerotherapy with tetracycline hydrochloride in simple renal cysts. Int Urol Nephrol 2008; 40: 609-13.
  • 26. Şimşek M, Kuloğlu T, Pala Ş, Boztosun A, Can B, Atilgan R. The effect of ethanol sclerotherapy of 5 minutes duration on cyst diameter and rat ovarian tissue in simple ovarian cysts. Drug Des Devel Ther 2015; 5; 9: 1341-7.
  • 27. UI Haq F, Mitchell SE, Tekes A, Weiss CR. Bleomycin foam treatment of venous malformations: a promising agent for effective treatment with minimal swelling. J Vasc Interv Radiol 2015; 26: 1484-93.
  • 28. Huang Y, Li P, Xia S, Zhuo Y, Wu L. Proapoptotic effect and the mechanism of action of pingyangmycin on cavernous hemangiomas. Exp Ther Med 2014; 7: 473-7.
  • 29. Muir T, Kirsten M, Fourie P, Dippenaar N, Ionescu GO. Intralesional bleomycin injection (IBI) treatment for haemangiomas and congenital vascular malformations. Pediatr Surg Int 2004; 19: 766-73.
  • 30. Zhi K, Wen Y, Li L, Ren W. The role of intralesional Pingyangmycin in the treatment of venous malformation of facial and maxillary region. Int J Pediatr Otorhinolaryngol 2008; 72: 593-7.
  • 31. Mabeta P, Davis PF. The mechanism of bleomycin in inducing haemangioma regression. SAMJ 2008; 98: 538-40.
  • 32. Li P, Li D-F, Guo Z-T, Xiao X. Therapeutic mechanism of bleomycin A5 on infancy hemangioma: an experimental study. Zhonghua Kou Qiang Yi Xue Za Zhi 2013; 48: 18-22.
  • 33. Li P, Xiao X, Guo Z-T. Effect of bleomycin A5 on the hemangioma-derived endothelial cell line XTPS-1. Zhonghua Kou Qiang Yi Xue Za Zhi 2012; 47: 324-8.
  • 34. Souftas VD, Kosmidou M, Karanikas M, Souftas D, Menexes G, Prassopoulos P. Symptomatic abdominal simple cysts: is percutaneous sclerotherapy with hypertonic saline and bleomycin a treatment option? Gastroenterol Res Pract 2015: 489363.
  • 35. Vlahovic A, Gazikalovic A, Adjic O. Bleomycin sclerotherapy for lymphatic malformation after unsuccessful surgical excision: case report. Acta Otorhinolaryngol Ital 2015; 35: 365-7.
  • 36. Azene E, Mitchell S, Radvany M, Agrawal N, Eisele D, Weiss C. Foamed bleomycin sclerosis of airway venous malformations: The role of interspecialty collaboration. Laryngoscope 2016; 126: 2726-32.
APA Bakal U, SARAÇ M, TARTAR T, Atilgan R, KULOĞLU T, dagli a, Kazez A (2020). Efficacy of Sclerotherapic Agents in the Treatment of Simple Ovarian Cysts Created by Experimental Rat Model. , 200 - 206. 10.4274/imj.galenos.2020.52296
Chicago Bakal Unal,SARAÇ Mehmet,TARTAR TUGAY,Atilgan Remzi,KULOĞLU TUNCAY,dagli adile ferda,Kazez Ahmet Efficacy of Sclerotherapic Agents in the Treatment of Simple Ovarian Cysts Created by Experimental Rat Model. (2020): 200 - 206. 10.4274/imj.galenos.2020.52296
MLA Bakal Unal,SARAÇ Mehmet,TARTAR TUGAY,Atilgan Remzi,KULOĞLU TUNCAY,dagli adile ferda,Kazez Ahmet Efficacy of Sclerotherapic Agents in the Treatment of Simple Ovarian Cysts Created by Experimental Rat Model. , 2020, ss.200 - 206. 10.4274/imj.galenos.2020.52296
AMA Bakal U,SARAÇ M,TARTAR T,Atilgan R,KULOĞLU T,dagli a,Kazez A Efficacy of Sclerotherapic Agents in the Treatment of Simple Ovarian Cysts Created by Experimental Rat Model. . 2020; 200 - 206. 10.4274/imj.galenos.2020.52296
Vancouver Bakal U,SARAÇ M,TARTAR T,Atilgan R,KULOĞLU T,dagli a,Kazez A Efficacy of Sclerotherapic Agents in the Treatment of Simple Ovarian Cysts Created by Experimental Rat Model. . 2020; 200 - 206. 10.4274/imj.galenos.2020.52296
IEEE Bakal U,SARAÇ M,TARTAR T,Atilgan R,KULOĞLU T,dagli a,Kazez A "Efficacy of Sclerotherapic Agents in the Treatment of Simple Ovarian Cysts Created by Experimental Rat Model." , ss.200 - 206, 2020. 10.4274/imj.galenos.2020.52296
ISNAD Bakal, Unal vd. "Efficacy of Sclerotherapic Agents in the Treatment of Simple Ovarian Cysts Created by Experimental Rat Model". (2020), 200-206. https://doi.org/10.4274/imj.galenos.2020.52296
APA Bakal U, SARAÇ M, TARTAR T, Atilgan R, KULOĞLU T, dagli a, Kazez A (2020). Efficacy of Sclerotherapic Agents in the Treatment of Simple Ovarian Cysts Created by Experimental Rat Model. İstanbul Medical Journal, 21(3), 200 - 206. 10.4274/imj.galenos.2020.52296
Chicago Bakal Unal,SARAÇ Mehmet,TARTAR TUGAY,Atilgan Remzi,KULOĞLU TUNCAY,dagli adile ferda,Kazez Ahmet Efficacy of Sclerotherapic Agents in the Treatment of Simple Ovarian Cysts Created by Experimental Rat Model. İstanbul Medical Journal 21, no.3 (2020): 200 - 206. 10.4274/imj.galenos.2020.52296
MLA Bakal Unal,SARAÇ Mehmet,TARTAR TUGAY,Atilgan Remzi,KULOĞLU TUNCAY,dagli adile ferda,Kazez Ahmet Efficacy of Sclerotherapic Agents in the Treatment of Simple Ovarian Cysts Created by Experimental Rat Model. İstanbul Medical Journal, vol.21, no.3, 2020, ss.200 - 206. 10.4274/imj.galenos.2020.52296
AMA Bakal U,SARAÇ M,TARTAR T,Atilgan R,KULOĞLU T,dagli a,Kazez A Efficacy of Sclerotherapic Agents in the Treatment of Simple Ovarian Cysts Created by Experimental Rat Model. İstanbul Medical Journal. 2020; 21(3): 200 - 206. 10.4274/imj.galenos.2020.52296
Vancouver Bakal U,SARAÇ M,TARTAR T,Atilgan R,KULOĞLU T,dagli a,Kazez A Efficacy of Sclerotherapic Agents in the Treatment of Simple Ovarian Cysts Created by Experimental Rat Model. İstanbul Medical Journal. 2020; 21(3): 200 - 206. 10.4274/imj.galenos.2020.52296
IEEE Bakal U,SARAÇ M,TARTAR T,Atilgan R,KULOĞLU T,dagli a,Kazez A "Efficacy of Sclerotherapic Agents in the Treatment of Simple Ovarian Cysts Created by Experimental Rat Model." İstanbul Medical Journal, 21, ss.200 - 206, 2020. 10.4274/imj.galenos.2020.52296
ISNAD Bakal, Unal vd. "Efficacy of Sclerotherapic Agents in the Treatment of Simple Ovarian Cysts Created by Experimental Rat Model". İstanbul Medical Journal 21/3 (2020), 200-206. https://doi.org/10.4274/imj.galenos.2020.52296